Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GEN-001 |
Synonyms | |
Therapy Description |
GEN-001 is a microbiome therapy derived from a single strain of bacteria isolated from healthy donors that, upon delivery, may produce metabolites that increase expression of interleukins (IL7 and IL15) and activate dendritic cells and macrophages, potentially resulting in the induction of cytotoxic immune response against tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GEN-001 | GEN 001|GEN001 | Microbiome 7 | GEN-001 is a microbiome therapy derived from a single strain of bacteria isolated from healthy donors that, upon delivery, may produce metabolites that increase expression of interleukins (IL7 and IL15) and activate dendritic cells and macrophages, potentially resulting in the induction of cytotoxic immune response against tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|